Minami Maeda

Executive Officer at Rakuten Medical.

Raised on Rakuten Medical filings

$113.4M

of $118.5M offered across 3 Form D filings

Form D filings: 3
Teammates: 15
Last filing: Apr 13, 2026

Company

Rakuten Medical

Biotech · San Diego, CA

Photoimmunotherapy drugs that target cancer cells

Photoimmunotherapy drugs that target cancer cells

Investors: 15
Still open: $5.2M

Investors: 15
Sector: Biotech
HQ: San Diego, CA

Rakuten Medical filings

Rakuten Medical Form D filings
Filed	Security	Sold of offered	Filing
Apr 13, 2026	Equity	$111.5M/ $116.7M	Form D
May 7, 2025	Security to be acquired	$1.9M/ $1.9M	Form D/A
Feb 5, 2025	Security to be acquired	$1.4M/ $1.4M	Form D

EquityFiled Apr 13, 2026Form D
$111.5M/ $116.7M
Security to be acquiredFiled May 7, 2025Form D/A
$1.9M/ $1.9M
Security to be acquiredFiled Feb 5, 2025Form D
$1.4M/ $1.4M

Works with

Also named on Rakuten Medical filings

Tiffany PiecewiczSecretary, Form D signerForm D signer Eiichi KagaDirector Suzane SanExecutive Officer Miguel Garcia-GuzmanDirector Abhijit BhatiaExecutive Officer Carlos GarciaExecutive Officer David ChaoDirector Hiroshi MikitaniExecutive Officer, Director Hiroshi MoriDirector Hiroyuki KodamaExecutive Officer Kentaro HyakunoDirector Maeda MinamiExecutive Officer Mazen DarwazahDirector Nitin NohriaDirector Toshiaki SuzukiExecutive Officer